BRPI0915527A2 - pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos - Google Patents

pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos

Info

Publication number
BRPI0915527A2
BRPI0915527A2 BRPI0915527A BRPI0915527A BRPI0915527A2 BR PI0915527 A2 BRPI0915527 A2 BR PI0915527A2 BR PI0915527 A BRPI0915527 A BR PI0915527A BR PI0915527 A BRPI0915527 A BR PI0915527A BR PI0915527 A2 BRPI0915527 A2 BR PI0915527A2
Authority
BR
Brazil
Prior art keywords
pepitides
exosomes
methods
same
pharmaceutical composition
Prior art date
Application number
BRPI0915527A
Other languages
English (en)
Portuguese (pt)
Inventor
Ryuji Ohsawa
Sachiko Yoshimura
Takukya Tsunoda
Tomohisa Watanabe
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of BRPI0915527A2 publication Critical patent/BRPI0915527A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C07K14/4706—Guanosine triphosphatase activating protein, GAP
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0915527A 2008-06-11 2009-06-10 pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos BRPI0915527A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6053808P 2008-06-11 2008-06-11
PCT/JP2009/002613 WO2009150835A1 (en) 2008-06-11 2009-06-10 Iqgap3 epitope peptides and vaccines containing the same

Publications (1)

Publication Number Publication Date
BRPI0915527A2 true BRPI0915527A2 (pt) 2016-01-26

Family

ID=41416549

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0915527A BRPI0915527A2 (pt) 2008-06-11 2009-06-10 pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos

Country Status (13)

Country Link
US (1) US20110200626A1 (enExample)
EP (1) EP2303909A4 (enExample)
JP (1) JP2011523937A (enExample)
KR (1) KR20110036903A (enExample)
CN (1) CN102119169A (enExample)
AU (1) AU2009258788A1 (enExample)
BR (1) BRPI0915527A2 (enExample)
CA (1) CA2727485A1 (enExample)
IL (1) IL209869A0 (enExample)
MX (1) MX2010013680A (enExample)
RU (1) RU2010154081A (enExample)
TW (1) TW201000115A (enExample)
WO (1) WO2009150835A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI580431B (zh) 2008-08-19 2017-05-01 腫瘤療法 科學股份有限公司 Ｈｉｇ２與ｕｒｌｃ１０抗原決定位胜肽以及含此胜肽之疫苗
TW201134480A (en) * 2010-04-08 2011-10-16 Oncotherapy Science Inc CLUAP1 peptides and vaccines including the same
GB201515321D0 (en) 2015-08-28 2015-10-14 Immatics Biotechnologies Gmbh Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
TWI796642B (zh) 2015-08-28 2023-03-21 德商英麥提克生物技術股份有限公司 用於多種癌症之免疫治療的新穎胜肽、胜肽的組合物及支架
GB201520542D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
KR102292655B1 (ko) 2017-04-26 2021-08-23 지브이에스 필트레이션, 인코포레이티드 다중 비드 에어 필터 씰
CN112521455B (zh) * 2020-12-08 2022-09-02 长春理工大学 一种检测膀胱癌抗原蛋白特异性的多肽及其应用
CN118930633A (zh) * 2023-05-12 2024-11-12 中国科学院深圳先进技术研究院 肿瘤相关抗原表位肽及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001064835A2 (en) * 2000-02-28 2001-09-07 Hyseq, Inc. Novel nucleic acids and polypeptides
DE102004026135A1 (de) * 2004-05-25 2006-01-05 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide
JP5109131B2 (ja) * 2005-02-10 2012-12-26 オンコセラピー・サイエンス株式会社 膀胱癌を診断する方法
EP2305811A1 (en) * 2005-07-27 2011-04-06 Oncotherapy Science, Inc. Method of diagnosing smal cell lung cancer
EP2311986B1 (en) * 2005-07-27 2015-04-15 Oncotherapy Science, Inc. Method of diagnosing esophageal cancer

Also Published As

Publication number Publication date
CA2727485A1 (en) 2009-12-17
JP2011523937A (ja) 2011-08-25
US20110200626A1 (en) 2011-08-18
EP2303909A1 (en) 2011-04-06
TW201000115A (en) 2010-01-01
MX2010013680A (es) 2011-02-23
AU2009258788A1 (en) 2009-12-17
KR20110036903A (ko) 2011-04-12
WO2009150835A1 (en) 2009-12-17
IL209869A0 (en) 2011-02-28
RU2010154081A (ru) 2012-07-20
EP2303909A4 (en) 2012-10-31
CN102119169A (zh) 2011-07-06

Similar Documents

Publication Publication Date Title
BRPI0910503A2 (pt) compostos, composições farmacêuticas e respectivos usos.
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0915527A2 (pt) pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
BRPI1008709A2 (pt) composições e usos das mesmas.
BRPI1009324A2 (pt) compostos e/ou farmaceuticamente aceitáveis dos mesmos, composição farmacêutica e respectivos usos
BR112013015592A2 (pt) dericados de biciclo-[3.2.1]-octilamida e usos dos mesmos
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
BRPI0918502A2 (pt) aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos
BRPI0918652A2 (pt) Composições farmacêuticas e métodos de libração relacionadas.
HUE053357T2 (hu) Gyógyszerészeti készítmény és annak beadásai
BRPI0922233A2 (pt) compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
BRPI0912717A2 (pt) Composição farmacêutica, e, uso de 5-azacitidina
BRPI0822337A2 (pt) Folatos, composições e usos dos mesmos
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
BRPI0907453A2 (pt) Compostos, uso e preparação dos mesmos
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BRPI0914343A2 (pt) composição, produto, uso da composição e método
FI20086253L (fi) Sieniendoglukanaasit, niiden valmistus ja käyttö
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
FI20086250L (fi) Sieniendoglukanaasit, niiden valmistus ja käyttö
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.
IT1403847B1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A E 7A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2373 DE 28-06-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: C07K 14/47 (2006.01), A61K 39/00 (2006.01), C07K 7